Prof. Dr. Catia Marzolini

Wäfler, Noémie, Knüsli, José, Lhopitallier, Loïc, Senn, Nicolas, Marzolini, Catia, & Boillat-Blanco, Noémie. (2026). Screening for antibiotic residues among adults with respiratory infections in primary care in Switzerland: evaluating over-the-counter use and environmental exposure. Clinical Microbiology and Infection, 32, 196–198. https://doi.org/10.1016/j.cmi.2025.10.024

Zoe Klein , Sophia C Meyer , Isabella C Schoepf , Marc Weber , Christian W Thorball , Lene Ryom , Neeltje A Kootstra , Peter Reiss , Dominique L Braun , Maria C Thurnheer, Catia Marzolini , Christian R Kahlert , Enos Bernasconi , Matthias Cavassini , Annalisa Marinosci , Jacques Fellay , Roger D Kouyos , Huldrych F Günthard , Bruno Ledergerber, Philip E Tarr. (2026). Association of leukocyte count with death in people with HIV: A longitudinal study over 24 years. Plos One, 1–17. https://doi.org/10.1371/journal.pone.0340678

Ravix, Anne, Di Paolo, Ermindo Roberto, Dao, Kim, Perez, Maria-Helena, Crisinel, Pierre Alex, Buclin, Thierry, André, Pascal, Marzolini, Catia, Csajka, Chantal, & Guidi, Monia. (2025). Piperacillin dosing in pediatric patients and augmented renal clearance: are current guidelines sufficient to achieve therapeutic concentration coverage? Journal of Antimicrobial Chemotherapy, 80, 3419–3430. https://doi.org/10.1093/jac/dkaf387

Carrara, Sandro, Widmer, Nicolas, Rodino, Francesca, Du, Lin, Briki, Myriam, Decosterd, Laurent A., Marzolini, Catia, Buclin, Thierry, Thoma, Yann, & Guidi, Monia. (2025). Therapeutic Drug Monitoring and Point-of-Care Technologies: Opportunities and Current Challenges. Therapeutic Drug Monitoring, Publish Ahead of Print. https://doi.org/10.1097/FTD.0000000000001384

Ekobena, Pierre, Briki, Myriam, Dao, Kim, Marzolini, Catia, Andre, Pascal, Buclin, Thierry, Cavassini, Matthias, Guidi, Monia, Thoueille, Paul, Abela, I.A., Aebi-Popp, K., Anagnostopoulos, A., Battegay, M., Bernasconi, E., Braun, D.L., Bucher, H.C., Calmy, A., Ciuffi, A., Dollenmaier, G., et al. (2025). Population pharmacokinetics of bictegravir in real-world people with HIV. Journal of Antimicrobial Chemotherapy, 80, 2782–2789. https://doi.org/10.1093/jac/dkaf297

Meyer, Sophia C., Klein, Zoe, Schoepf, Isabella C., Thorball, Christian W., Labarile, Marco, Kootstra, Neeltje A., Reiss, Peter, Ryom, Lene, Braun, Dominique L., Thurnheer, Maria C., Marzolini, Catia, Kahlert, Christian R., Bernasconi, Enos, Cavassini, Matthias, Marinosci, Annalisa, Fellay, Jacques, Günthard, Huldrych F., Kouyos, Roger D., Ledergerber, Bruno, et al. (2025). Leukocyte count and new‐onset diabetes mellitus in people with HIV : A longitudinal study. HIV Medicine, 26(10), 1585–1599. https://doi.org/10.1111/hiv.70089

Thoueille, Paul, Marzolini, Catia, Guidi, Monia, Cavassini, Matthias, & Decosterd, Laurent A. (2025). Is Nonsustained Viral Suppression With Long-Acting Cabotegravir and Rilpivirine Really Independent of Drug Levels? Clinical Infectious Diseases, 81, e4–e5. https://doi.org/10.1093/cid/ciae616

Alagaratnam, Jasmini, van Bremen, Kathrin, Behrens, Georg M N, Boccara, Franck, Cinque, Paola, Gisslén, Magnus, Guaraldi, Giovanni, Konopnicki, Deborah, Kowalska, Justyna D, Mallon, Patrick W G, Marzolini, Catia, Mendão, Luis, Miró, José M, Negredo, Eugenia, Reiss, Peter, Ryom, Lene, van der Valk, Marc, Winston, Alan, Nielsen, Susanne D, & Martínez, Esteban. (2025). Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular disease. Lancet HIV, 12(5), e382–e392. https://doi.org/10.1016/s2352-3018(25)00047-5

D’Atri, V., Corrado, F., Versace, F., Saldanha, S. A., Mercier, T., Guidi, M., Thoueille, P., Blanchon, S., Koutsokera, A., Vogeser, M., Marzolini, C., Girardin, F., Mitropoulou, G., Balmpouzis, Z., Rochat, I., Sauty, A., Decosterd, L. A., & Choong, E. (2025). A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring [Journal-article]. Molecules, 30(9), 1866. https://doi.org/10.3390/molecules30091866

Pallanza, Micol, Thoueille, Paul, Briki, Myriam, Alves Saldanha, Susana, Cavassini, Matthias, & Marzolini, Catia. (2025). Sustained viral suppression with once daily dolutegravir-containing regimen in presence of the strong inducer carbamazepine. Antiviral Therapy, 30(2). https://doi.org/10.1177/13596535251335080

Haefliger, David, Mina, Lynn, Guidi, Monia, Marzolini, Catia, Thoueille, Paul, Rothuizen, Laura E., Thoma, Yann, Decosterd, Laurent A., Guery, Benoit, Girardin, François R., & Buclin, Thierry. (2025). Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysis. Journal of Antimicrobial Chemotherapy, 80(3), 840–847. https://doi.org/10.1093/jac/dkaf007

Ambrosioni, Juan, Levi, Laura I., Alagaratnam, Jasmini, Sempere, Abiu, Mastrangelo, Andrea, Paioni, Paolo, Mussini, Cristina, Marzolini, Catia, Nielsen, Susanne Dam, Béguelin, Charles, Welch, Steven, Koval, Anna, Mendao, Luis, Bamford, Alasdair, Calmy, Alexandra, Guaraldi, Giovanni, Oprea, Cristiana, Martínez, Esteban, & Rockstroh, Jürgen K. (2025). Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025. HIV Medicine. https://doi.org/10.1111/hiv.70120

Hilfiker, Anina, Schoepf, Isabella C., Avery, Emma F., Ledergerber, Bruno, Colin-Benoit, Eugénie, Riebensahm, Carlotta, Marzolini, C., Kahlert, Christian R., Bernasconi, E., Cavassini, M., Marinosci, Annalisa, Günthard, H.F., Kouyos, Roger, Nemeth, J., Tarr, Philip E., Abela, I.A., Aebi-Popp, K., Anagnostopoulos, A., Battegay, M., et al. (2025). Mycobacterium tuberculosis Infection and Acute or Subclinical Coronary Artery Disease: the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes 1999. https://doi.org/10.1097/QAI.0000000000003714

Kuriakose S, Tseng A, Boyd S, Gibbons S, Chiong J, Marra F, Boyle A, Senneker T, George J, Lund C, Belperio P, Crew P, Eschenauer G, Scarsi K, Khoo S, Pau A, Marzolini C. (2025). International collaboration to develop and harmonize drug interaction guidance for nirmatrelvir/ritonavir during COVID-19: lessons learned for future pandemic preparedness. Clinical Infectious Diseases.

Marzolini C. (2025). Is Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine of Clinical Utility? Clinical Infectious Diseases, 1–3.

Marzolini, Catia, Gibbons, Sara, Seddon, Daniel, & Khoo, Saye. (2025). Drug-drug interactions potential with the HIV-1 capsid inhibitor lenacapavir. Expert Opinion on Drug Metabolism and Toxicology, 21(2), 161–172. https://doi.org/10.1080/17425255.2024.2415295

Sukumaran, Luxsena, Winston, Alan, Marzolini, Catia, Khoo, Saye, Boffito, Marta, Naous, Nadia, & Sabin, Caroline A. (2025). Polypharmacy in HIV: Rethinking what counts and why it matters. HIV Medicine. https://doi.org/10.1111/hiv.70129

Tachet, Jérémie, Marzolini, Catia, Decosterd, Laurent A., Guidi, Monia, & Girardin, François R. (2025). Therapeutic drug monitoring of Janus kinase inhibitors for precision dosing: where do we stand ? Expert Review of Clinical Pharmacology, 18, 753–769. https://doi.org/10.1080/17512433.2025.2576698

Pham, Thao, Ghafoor, Mohamed, Grañana-Castillo, Sandra, Marzolini, Catia, Gibbons, Sara, Khoo, Saye, Chiong, Justin, Wang, Dennis, & Siccardi, Marco. (2024). DeepARV: ensemble deep learning to predict drug-drug interaction of clinical relevance with antiretroviral therapy [Journal-article]. npj Systems Biology and Applications, 10(1). https://doi.org/10.1038/s41540-024-00374-0

Damas, José, Munting, Aline, Fellay, J., Haerry, D., Marzolini, C., Tarr, P., Steffen, Ana, Braun, Dominique L., Stoeckle, Marcel, Bernasconi, E., Nawej Tshikung, Olivier, Fux, C.A., Darling, Katharine E. A., Béguelin, Charles, Wandeler, G., Cavassini, M., Surial, Bernard, Abela, I., Aebi-Popp, K., et al. (2024). Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV. Clinical Infectious Diseases, 79, 990–998. https://doi.org/10.1093/cid/ciae189

Berton, Mattia, Stader, Felix, Bettonte, Sara, Battegay, Manuel, & Marzolini, Catia. (2024). Ideal Time to Conduct a Pharmacokinetic Investigation After Delivery to Fully Capture the Effect of Pregnancy on Drug Exposure [Journal-article]. Open Forum Infectious Diseases, 11(10), 11. https://doi.org/10.1093/ofid/ofae585

Abela, Irene A, Chammartin, Frédérique, Amstutz, Alain, Surial, Bernard, Ballif, Marie, Marzolini, Catia, Aebi-Popp, Karoline, Notter, Julia, Segeral, Olivier, Stoeckle, Marcel, Cavassini, Matthias, Bernasconi, Enos, Günthard, Huldrych F, Kouyos, Roger D, & Pasin, Chloé. (2024). Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk. Open Forum Infectious Diseases, 11(9). https://doi.org/10.1093/ofid/ofae502

Haefliger, David, Chehade, Hassib, Livio, Francoise, Rodrigues-Veiga, Viviane, Diezi, Léonore, & Marzolini, Catia. (2024). Vancomycin Dosing Strategy for the Treatment of Peritonitis in a Child on Automated Peritoneal Dialysis: A First Pediatric Case Report. Seminars in Dialysis, 37(6), 461–465. https://doi.org/10.1111/sdi.13224

Bettonte, Sara, Berton, Mattia, Stader, Felix, Battegay, Manuel, & Marzolini, Catia. (2024). Effect of Obesity on the Exposure of Long-acting Cabotegravir and Rilpivirine: A Modeling Study [Journal-article]. Clinical Infectious Diseases, 79(2), 477–486. https://doi.org/10.1093/cid/ciae060

Bongiovanni, Marco, Thoueille, Paul, Barda, Beatrice, Mercier, Thomas, Marzolini, Catia, Ramponi, Niccolò, Choong, Eva, Cantù, Marco, Decosterd, Laurent A., & Bernasconi, Enos. (2024). Oritavancin use in patients with recurrent bone infections by methicillin-resistant Staphylococcus aureus with monitoring of concentrations [Journal-article]. European Journal of Clinical Microbiology and Infectious Diseases, 43(7), 1503–1504. https://doi.org/10.1007/s10096-024-04844-5

Thoueille, Paul, Saldanha, Susana Alves, Schaller, Fabian, Choong, Eva, Veuve, François, Munting, Aline, Cavassini, Matthias, Braun, Dominique, Günthard, Huldrych F., Duran Ramirez, Jessy J., Surial, Bernard, Furrer, Hansjakob, Rauch, Andri, Ustero, Pilar, Calmy, Alexandra, Stöckle, Marcel, Di Benedetto, Caroline, Bernasconi, Enos, Schmid, Patrick, et al. (2024). Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV [Journal-article]. Clinical Pharmacology and Therapeutics, 115(6), 1450–1459. https://doi.org/10.1002/cpt.3240

Bettonte, Sara, Berton, Mattia, Battegay, Manuel, Stader, Felix, & Marzolini, Catia. (2024). Development of a physiologically-based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs [Journal-article]. CPT: Pharmacometrics and Systems Pharmacology, 13(5), 781–794. https://doi.org/10.1002/psp4.13118

Bettonte, Sara, Berton, Mattia, Stader, Felix, Battegay, Manuel, & Marzolini, Catia. (2024). Drug Exposure of Long-Acting Cabotegravir and Rilpivirine in Older People With Human Immunodeficiency Virus: A Pharmacokinetic Modeling Study [Journal-article]. Open Forum Infectious Diseases, 11(4). https://doi.org/10.1093/ofid/ofae171

Briki, M., Murisier, A., Guidi, M., Seydoux, C., Buclin, T., Marzolini, C., Girardin, F.R., Thoma, Y., Carrara, S., Choong, E., & Decosterd, L.A. (2024). Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update [Journal-article]. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1236, 124039. https://doi.org/10.1016/j.jchromb.2024.124039

Thoueille, Paul, Delarive, Luc, Cavassini, Matthias, Buclin, Thierry, Decosterd, Laurent A., Marzolini, Catia, Girardin, François R., & Guidi, Monia. (2024). Population pharmacokinetic analysis of doravirine in real-world people with HIV. British Journal of Clinical Pharmacology, 90(4), 1058–1065. https://doi.org/10.1111/bcp.15975

Ambrosioni, Juan, Díaz, Natalia Anahí, Marzolini, Catia, Dragovic, Gordana, Imaz, Arkaitz, Calcagno, Andrea, Luque, Sonia, Curran, Adrian, Troya, Jesus, Tuset, Montse, Khoo, Saye, Burger, David, Cortés, Claudia P., Naous, Nadia, & Molto, Jose. (2024). Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study. Infectious Diseases and Therapy, 13(3), 609–617. https://doi.org/10.1007/s40121-024-00935-0

Thoueille, Paul, Cavassini, Matthias, Guidi, Monia, Buclin, Thierry, Girardin, François R., Decosterd, Laurent A., & Marzolini, Catia. (2024). Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures. Open Forum Infectious Diseases, 11(2). https://doi.org/10.1093/ofid/ofae023

Berton, Mattia, Bettonte, Sara, Stader, Felix, Decosterd, Laurent, Tarr, Philip E., Livio, Françoise, Cavassini, Matthias, Braun, Dominique L., Kusejko, Katharina, Hachfeld, Anna, Bernasconi, Enos, Calmy, Alexandra, Schmid, Patrick, Battegay, Manuel, & Marzolini, Catia. (2024). Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data. Clinical Infectious Diseases, 78(1), 98–110. https://doi.org/10.1093/cid/ciad495

Thoueille, Paul, Saldanha, Susana Alves, Schaller, Fabian, Choong, Eva, Munting, Aline, Cavassini, Matthias, Braun, Dominique, Günthard, Huldrych F., Kusejko, Katharina, Surial, Bernard, Furrer, Hansjakob, Rauch, Andri, Rougemont, Mathieu, Ustero, Pilar, Calmy, Alexandra, Stöckle, Marcel, Marzolini, Catia, Di Benedetto, Caroline, Bernasconi, Enos, et al. (2024). Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland. The Lancet Regional Health - Europe, 36. https://doi.org/10.1016/j.lanepe.2023.100793

Thoueille, Paul, Saldanha, Susana Alves, Schaller, Fabian, Choong, Eva, Veuve, François, Munting, Aline, Cavassini, Matthias, Braun, Dominique, Günthard, Huldrych F., Duran Ramirez, Jessy J., Surial, Bernard, Furrer, Hansjakob, Rauch, Andri, Ustero, Pilar, Calmy, Alexandra, Stöckle, Marcel, Di Benedetto, Caroline, Bernasconi, Enos, Schmid, Patrick, et al. (2024). Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1437400

Bettonte S, Berton M, Stader F, Battegay M, & Marzolini C. (2023). Intramuscular cabotegravir and rilpivirine concentrations after switching from efavirenz-containing regimen. British Journal of Clinical Pharmacology, 89(12), 3618–3628. https://doi.org/10.1111/bcp.15867

Erba A, Marzolini C, Rentsch K, Stoeckle M, Battegay M, Mayr M, & Weisser M. (2023). Switch from a ritonavir to a cobicistat containing antiretroviral regimen and impact on tacrolimus levels in a kidney transplant recipient. Virology Journal, 20(1), 89. https://doi.org/10.1186/s12985-023-02058-3

Ambrosioni, Juan, Levi, Laura, Alagaratnam, Jasmini, Van Bremen, Kathrin, Mastrangelo, Andrea, Waalewijn, Hylke, Molina, Jean-Michel, Guaraldi, Giovanni, Winston, Alan, Boesecke, Christoph, Cinque, Paola, Bamford, Alasdair, Calmy, Alexandra, Marzolini, Catia, Martínez, Esteban, Oprea, Cristiana, Welch, Steven, Koval, Anna, Mendao, Luis, & Rockstroh, Jürgen K. (2023). Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023. HIV Medicine, 24(11), 1126–1136. https://doi.org/10.1111/hiv.13542

Sebastiani G, Milic J, Tsochatzis EA, Marzolini C, Betel M, Bhagani S, Morse CG, Cinque F, Maurice JB, Ingiliz P, Price J, Lemoine M, Rockstroh JK, Guaraldi G, & Steatohepatitis in HIV Emerging Research (SHIVER) Network. (2023). Letter to the Editor: People living with HIV and NAFLD—A population left behind in the global effort for liver fibrosis screening? Hepatology, 78(5), E87–E88. https://doi.org/10.1097/hep.0000000000000465

Schwenke, Johannes M, Thorball, Christian W, Schoepf, Isabella C, Ryom, Lene, Hasse, B., Lamy, Olivier, Calmy, A., Wandeler, G., Marzolini, C., Kahlert, C.R., Bernasconi, E., Kouyos, R.D., Günthard, H.F., Ledergerber, Bruno, Fellay, J., Burkhalter, Felix, Tarr, P., Abela, I., Aebi-Popp, K., et al. (2023). Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study. Journal of Infectious Diseases, 228, 742–750. https://doi.org/10.1093/infdis/jiad179

Marzolini C, Cavassini M, Braun DL, Hachfeld A, Bernasconi E, Calmy A, Schmid P, Battegay M, Elzi L, & Swiss HIV Cohort Study. (2023). Effect of SLCO1B1 c.521T> C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor-containing regimen. British Journal of Clinical Pharmacology, 89(9), 2739–2746. https://doi.org/10.1111/bcp.15754

Paioni, P., Aebi-Popp, K., Martinez de Tejada, B., Rudin, Christoph, Bernasconi, E., Braun, Dominique L., Kouyos, R.D., Wagner, Noémie, Crisinel, P.A., Güsewell, Sabine, Darling, K., Duppenthaler, A., Baumann, Marc, Polli, Ch, Fischer, Tina, Kahlert, C.R., Abela, I., Aebi-Popp, K., Anagnostopoulos, A., et al. (2023). Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study. Lancet Regional Health Europe, 31. https://doi.org/10.1016/j.lanepe.2023.100656

Berton M, Bettonte S, Stader F, Battegay M, & Marzolini C. (2023). Impact of Obesity on the Drug-Drug Interaction Between Dolutegravir and Rifampicin or Any Other Strong Inducers. Open Forum Infectious Diseases, 10(7), ofad361. https://doi.org/10.1093/ofid/ofad361

Bettonte S, Berton M, Stader F, Battegay M, & Marzolini C. (2023). Management of Drug Interactions with Inducers: Onset and Disappearance of Induction on Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyltransferase 1A1 Substrates. European Journal of Drug Metabolism and Pharmacokinetics, 48(4), 353–362. https://doi.org/10.1007/s13318-023-00833-9

Haefliger D, Marzolini C, Lamoth F, Pabst T, Buclin T, & Livio F. (2023). Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole (Patent No. 7). British Journal of Clinical Pharmacology, 89(7), Article 7. https://doi.org/10.1111/bcp.15743

Avery, Emma F, Kleynhans, Julia N, Ledergerber, Bruno, Schoepf, Isabella C, Thorball, Christian W, Kootstra, Neeltje A, Reiss, Peter, Ryom, Lene, Braun, Dominique L, Thurnheer, Maria C, Marzolini, Catia, Seneghini, Marco, Bernasconi, Enos, Cavassini, Matthias, Buvelot, Hélène, Kouyos, Roger D, Fellay, Jacques, Günthard, Huldrych F, Tarr, Philip E, & The Swiss HIV Cohort Study. (2023). Leukocyte Count and Coronary Artery Disease Events in People with Human Immunodeficiency Virus: A Longitudinal Study. Clinical Infectious Diseases, 76(11), 1969–1979. https://doi.org/10.1093/cid/ciad033

Schoepf, Isabella C, Esteban-Cantos, Andrés, Thorball, Christian W, Rodés, Berta, Reiss, Peter, Rodríguez-Centeno, Javier, Riebensahm, Carlotta, Braun, Dominique L, Marzolini, Catia, Seneghini, Marco, Bernasconi, Enos, Cavassini, Matthias, Buvelot, Hélène, Thurnheer, Maria Christine, Kouyos, Roger D, Fellay, Jacques, Günthard, Huldrych F, Arribas, José R, Ledergerber, Bruno, & Tarr, Philip E. (2023). Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years. The Lancet Healthy Longevity, 4(5), e211–e218. https://doi.org/10.1016/s2666-7568(23)00037-5

Schoepf, Isabella C, Esteban-Cantos, Andrés, Thorball, Christian W, Rodés, Berta, Reiss, Peter, Rodríguez-Centeno, Javier, Riebensahm, Carlotta, Braun, Dominique L, Marzolini, Catia, Seneghini, Marco, Bernasconi, Enos, Cavassini, Matthias, Buvelot, Hélène, Thurnheer, Maria Christine, Kouyos, Roger D, Fellay, Jacques, Günthard, Huldrych F, Arribas, José R, Ledergerber, Bruno, & Tarr, Philip E. (2023). Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years [Journal-article]. The Lancet Healthy Longevity, 4(5), e211–e218. https://doi.org/10.1016/s2666-7568(23)00037-5

Bettonte S, Berton M, Stader F, Battegay M, & Marzolini C. (2023). Management of Drug-Drug Interactions between Long-Acting Cabotegravir and Rilpivirine and Comedications with Inducing Properties: A Modeling Study. Clinical Infectious Diseases, 76(7), 1225–1236. https://doi.org/10.1093/cid/ciac901

Marzolini C, & Khoo S. (2023). Response to “A Case Report of Safe Coadministration of Amioradone With Short-Term Treatment Nirmatrelvir-Ritonavir” (Patent No. 4). Clinical Pharmacology and Therapeutics, 113(4), Article 4. https://doi.org/10.1002/cpt.2809

Berton M, Bettonte S, Stader F, Battegay M, & Marzolini C. (2023). Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals. Clinical Pharmacokinetics, 62(2), 277–295. https://doi.org/10.1007/s40262-022-01194-3

Hodge, Daryl, Hodel, Eva Maria, Hughes, Elen, Hazenberg, Phoebe, Grañana Castillo, Sandra, Gibbons, Sara, Wang, Duolao, Marra, Fiona, Marzolini, Catia, Back, David, & Khoo, Saye. (2023). Prevalence of Potentially Clinically Significant Drug-Drug Interactions with Antiretrovirals Against HIV over Three Decades: A Systematic Review of the Literature [Journal-article]. Journal of Acquired Immune Deficiency Syndromes, 92(2), 97–105. https://doi.org/10.1097/qai.0000000000003122

Bettonte S, Berton M, & Marzolini C. (2023). What is the significance of the pharmacokinetic profile and potential drug–drug interactions of long-acting intramuscular cabotegravir and rilpivirine? (Patent No. 5). Expert Opinion on Drug Metabolism and Toxicology, 19(5), Article 5. https://doi.org/10.1080/17425255.2023.2223961

Thoueille, P., Alves Saldanha, S., Schaller, F., Choong, E., Munting, A., Cavassini, M., Braun, D., Günthard, H. F., Kusejko, K., Surial, B., Furrer, H., Rauch, A., Rougemont, M., Ustero, P., Calmy, A., Stoeckle, M., Marzolini, C., Di Benedetto, C., Bernasconi, E., et al. (2023). Real-World Trough Concentrations and Effectiveness of Long-Acting Cabotegravir and Rilpivirine: A Multicenter Prospective Observational Study in Switzerland [Posted-content]. Elsevier BV. https://doi.org/10.2139/ssrn.4584084

Aebi-Popp K, Kahlert CR, Crisinel PA, Decosterd L, Saldanha SA, Hoesli I, Martinez De Tejada B, Duppenthaler A, Rauch A, Marzolini C, & Swiss Mother and Child HIV Cohort Study (SHCS). (2022). Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study. Journal of Antimicrobial Chemotherapy, 77(12), 3436–3442. https://doi.org/10.1093/jac/dkac337

Marzolini C, Kuritzkes DR, Marra F, Boyle A, Gibbons S, Flexner C, Pozniak A, Boffito M, Waters L, Burger D, Back DJ, & Khoo S. (2022). Recommendations for the Management of Drug–Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications. Clinical Pharmacology and Therapeutics, 112(6), 1191–1200. https://doi.org/10.1002/cpt.2646

Berton M, Bettonte S, Stader F, Battegay M, & Marzolini C. (2022). Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models. Clinical Pharmacokinetics, 61(9), 1251–1270. https://doi.org/10.1007/s40262-022-01132-3

Franchini F, Kusejko K, Marzolini C, Tellenbach C, Rossi S, Stampf S, Koller M, Stoyanov J, Möller B, & Leichtle AB. (2022). Collaborative Challenges of Multi-Cohort Projects in Pharmacogenetics—Why Time Is Essential for Meaningful Collaborations. JMIR Formative Research, 6(9), e36759. https://doi.org/10.2196/36759

Jakeman, Bernadette, Scherrer, Alexandra U., Darling, Katharine E.A., Damas, Jose, Bieler-Aeschlimann, Melanie, Hasse, Barbara, Schlosser, Ladina, Hachfeld, Anna, Gutbrod, Klemens, Tarr, Philip E., Calmy, Alexandra, Assal, Frederic, Kunze, Ursula, Stoeckle, Marcel, Schmid, Patrick, Toller, Gianina, Rossi, Stefania, di Benedetto, Caroline, du Pasquier, Renaud, et al. (2022). Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus. Open Forum Infectious Diseases, 9(9). https://doi.org/10.1093/ofid/ofac457

Ryom L, De Miguel R, Cotter AG, Podlekareva D, Beguelin C, Waalewijn H, Arribas JR, Mallon PWG, Marzolini C, Kirk O, Bamford A, Rauch A, Molina JM, Kowalska JD, Guaraldi G, Winston A, Boesecke C, Cinque P, Welch S, et al. (2022). Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021. HIV Medicine, 23(8), 849–858. https://doi.org/10.1111/hiv.13268

Girardin F, Manuel O, Marzolini C, & Buclin T. (2022). Evaluating the risk of drug-drug interactions with pharmacokinetic boosters: the case of ritonavir-enhanced nirmatrelvir to prevent severe COVID-19. Clinical Microbiology and Infection, 28(8), 1044–1046. https://doi.org/10.1016/j.cmi.2022.03.030

Thoueille P, Alves Saldanha S, Schaller F, Munting A, Cavassini M, Braun D, Günthard HF, Kusejko K, Surial B, Furrer H, Rauch A, Ustero P, Calmy A, Stoeckle M, Battegay M, Marzolini C, Andre P, Guidi M, Buclin T, et al. (2022). Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland. Pharmaceutics, 14(8). https://doi.org/10.3390/pharmaceutics14081588

Otten LS, Piet B, van den Heuvel MM, Marzolini C, van Geel RMJM, Gulikers JL, Burger DM, Leentjens J, & Ter Heine R. (2022). Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer. European Respiratory Review, 31(164). https://doi.org/10.1183/16000617.0004-2022

Stader F, & Marzolini C. (2022). Sex-related pharmacokinetic differences with aging. European Geriatric Medicine, 13(3), 559–565. https://doi.org/10.1007/s41999-021-00587-0

Marzolini C, Kuritzkes DR, Marra F, Boyle A, Gibbons S, Flexner C, Pozniak A, Boffito M, Waters L, Burger D, Back D, & Khoo S. (2022). Prescribing Nirmatrelvir–Ritonavir: How to Recognize and Manage Drug–Drug Interactions (Patent No. 5). Annals of Internal Medicine, 175(5), Article 5. https://doi.org/10.7326/m22-0281

Schoepf, Isabella C., Thorball, Christian W., Ledergerber, Bruno, Kootstra, Neeltje A., Reiss, Peter, Raffenberg, Marieke, Engel, Tanja, Braun, Dominique L., Hasse, Barbara, Thurnheer, Christine, Marzolini, Catia, Seneghini, Marco, Bernasconi, Enos, Cavassini, Matthias, Buvelot, Hélène, Arribas, José R., Kouyos, Roger D., Fellay, Jacques, Günthard, Huldrych F., & Tarr, Philip E. (2022). Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over > 17 Years. Journal of Infectious Diseases, 225(9), 1581–1591. https://doi.org/10.1093/infdis/jiab603

Zino L, Kingma JS, Marzolini C, Richel O, Burger DM, & Colbers A. (2022). Implications of Bariatric Surgery on the Pharmacokinetics of Antiretrovirals in People Living with HIV. Clinical Pharmacokinetics, 61(5), 619–635. https://doi.org/10.1007/s40262-022-01120-7

Bettonte S, Berton M, & Marzolini C. (2022). Magnitude of Drug–Drug Interactions in Special Populations. Pharmaceutics, 14(4). https://doi.org/10.3390/pharmaceutics14040789

Jacobs TG, Marzolini C, Back DJ, & Burger DM. (2022). Dexamethasone is a dose-dependent perpetrator of drug-drug interactions: Implications for use in people living with HIV. Journal of Antimicrobial Chemotherapy, 77(3), 568–573. https://doi.org/10.1093/jac/dkab412

Marzolini C, Gibbons S, van Oosterhout JJ, & Khoo S. (2022). Drug–Drug Interaction Potential with Once-Weekly Isoniazid/Rifapentine (3HP) for the Treatment of Latent Tuberculosis Infection. Clinical Pharmacokinetics, 61(3), 339–346. https://doi.org/10.1007/s40262-021-01098-8

Marzolini C, Marra F, Boyle A, Khoo S, & Back DJ. (2022). Fluvoxamine for the treatment of COVID-19 (Patent No. 3). The Lancet Global Health, 10(3), Article 3. https://doi.org/10.1016/s2214-109x(21)00592-1

Stader F, Battegay M, Sendi P, & Marzolini C. (2022). Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID-19 Patients. Clinical Pharmacology and Therapeutics, 111(3), 579–584. https://doi.org/10.1002/cpt.2402

Jakeman B, Scherrer A, Battegay M, Gunthard HF, Hachfeld A, Calmy A, Schmid P, Bernasconi E, Cavassini M, & Marzolini C. (2022). Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: A prospective cohort study. Journal of Antimicrobial Chemotherapy, 77(2), 492–499. https://doi.org/10.1093/jac/dkab386

Scherrer AU, Traytel A, Braun DL, Calmy A, Battegay M, Cavassini M, Furrer H, Schmid P, Bernasconi E, Stoeckle M, Kahlert C, Trkola A, Kouyos RD, Tarr P, Marzolini C, Wandeler G, Fellay J, Bucher H, Yerly S, et al. (2022). Cohort Profile Update: The Swiss HIV Cohort Study (SHCS). International Journal of Epidemiology, 51(1), 33–34J. https://doi.org/10.1093/ije/dyab141

Allavena C, & Marzolini C. (2021). Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug-drug interactions? Lancet Healthy Longev, 2.

Hollinger, Alexa, Cueni, Nadine, Marzolini, Catia, Dickenmann, Michael, Landmann, Emmanuelle, Battegay, Manuel, Martinez, Aurélien Emmanuel, Siegemund, Martin, & Leuppi-Taegtmeyer, Anne. (2021). Lactic acidosis and hyperlactatemia associated with lamivudine accumulation and sepsis in a kidney transplant recipient—a case report and review of the literature. AIDS Research and Therapy, 18(1). https://doi.org/10.1186/s12981-021-00382-8

Schoepf IC, Thorball CW, Ledergerber B, Engel T, Raffenberg M, Kootstra NA, Reiss P, Hasse B, Marzolini C, Thurnheer C, Seneghini M, Bernasconi E, Cavassini M, Buvelot H, Kouyos R, Günthard HF, Fellay J, Tarr PE, & Swiss HIV Cohort Study. (2021). Coronary artery disease-associated and longevity-associated polygenic risk scores for prediction of coronary artery disease events in persons living with human immunodeficiency virus: The swiss hiv cohort study. Clinical Infectious Diseases, 73(9), 1597–1604. https://doi.org/10.1093/cid/ciab521

Stader F, Battegay M, & Marzolini C. (2021). Physiologically-Based Pharmacokinetic Modeling to Support the Clinical Management of Drug–Drug Interactions With Bictegravir. Clinical Pharmacology and Therapeutics, 110(5), 1231–1239. https://doi.org/10.1002/cpt.2221

Allavena C, & Marzolini C. (2021). Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug–drug interactions? (Patent No. 10). The Lancet Healthy Longevity, 2(10), Article 10. https://doi.org/10.1016/s2666-7568(21)00227-0

Courlet P, Guidi M, Alves Saldanha S, Cavassini M, Stoeckle M, Buclin T, Marzolini C, Decosterd LA, & Csajka C. (2021). Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs. European Journal of Clinical Pharmacology, 77(7), 979–987. https://doi.org/10.1007/s00228-020-03060-2

Hodge D, Back DJ, Gibbons S, Khoo SH, & Marzolini C. (2021). Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine. Clinical Pharmacokinetics, 60(7), 835–853. https://doi.org/10.1007/s40262-021-01005-1

Stader F, Courlet P, Decosterd LA, Battegay M, & Marzolini C. (2021). Physiologically-Based Pharmacokinetic Modeling Combined with Swiss HIV Cohort Study Data Supports No Dose Adjustment of Bictegravir in Elderly Individuals Living With HIV. Clinical Pharmacology and Therapeutics, 109(4), 1025–1029. https://doi.org/10.1002/cpt.2178

Courlet P, Guidi M, Alves Saldanha S, Stader F, Traytel A, Cavassini M, Stoeckle M, Buclin T, Marzolini C, Decosterd LA, Csajka C, & and the Swiss HIV Cohort Study. (2021). Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV. Clinical Pharmacokinetics, 60(3), 379–390. https://doi.org/10.1007/s40262-020-00946-3

Marra F, Smolders EJ, El-Sherif O, Boyle A, Davidson K, Sommerville AJ, Marzolini C, Siccardi M, Burger D, Gibbons S, Khoo S, & Back D. (2021). Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment. Drugs in R and D, 21(1), 9–27. https://doi.org/10.1007/s40268-020-00333-0

Marzolini C, Stader F, Leuppi-Taegtmeyer A, Stoeckle M, Battegay M, & Sendi P. (2021). Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19 (Patent No. 2). Drug Safety, 44(2), Article 2. https://doi.org/10.1007/s40264-020-01025-z

Back, David, Marzolini, Catia, Hodge, Catherine, Marra, Fiona, Boyle, Alison, Gibbons, Sara, Burger, David, & Khoo, Saye. (2021). COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions. British Journal of Clinical Pharmacology, 87(1), 212–213. https://doi.org/10.1111/bcp.14358

Deutschmann, Elisabeth, Bucher, Heiner C., Jaeckel, Steffen, Gibbons, Sara, McAllister, Katie, Scherrer, Alexandra U., Braun, Dominique L., Cavassini, Matthias, Hachfeld, Anna, Calmy, Alexandra, Battegay, Manuel, Cipriani, Michela, Elzi, Luigia, Young, James, Lopez-Centeno, Beatriz, Berenguer, Juan, Khoo, Saye, Moffa, Giusi, Marzolini, Catia, & Swiss HIV Cohort Study. (2021). Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors. Clinical Infectious Diseases, 73(7), e2145–e2152. https://doi.org/10.1093/cid/ciaa918

Istampoulouoglou I, Zimmermanns B, Grandinetti T, Marzolini C, Harings-Kaim A, Koechlin-Lemke S, Scholz I, Bassetti S, & Leuppi-Taegtmeyer AB. (2021). Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre. Global Cardiology Science and Practice, 2021(2), e202111. https://doi.org/10.21542/gcsp.2021.11

Kümmerle, A., Sikalengo, G., Vanobberghen, F., Ndege, R. C., Foe, G., Schlaeppi, C., Burri, C., Battegay, M., Paris, D. H., Glass, T. R., Weisser, M., Marzolini, C., & Kiularco Study Group. (2021). Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based study. J Antimicrob Chemother, 76(10), 2681–2689. https://doi.org/10.1093/jac/dkab254

Mari, Alfredo, Roloff, Tim, Stange, Madlen, Søgaard, Kirstine K., Asllanaj, Erblin, Tauriello, Gerardo, Alexander, Leila Tamara, Schweitzer, Michael, Leuzinger, Karoline, Gensch, Alexander, Martinez, Aurélien E., Bielicki, Julia, Pargger, Hans, Siegemund, Martin, Nickel, Christian H., Bingisser, Roland, Osthoff, Michael, Bassetti, Stefano, Sendi, Parham, et al. (2021). Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance. Microorganisms, 9(5), 1094. https://doi.org/10.3390/microorganisms9051094

Marzolini, Catia, Battegay, Manuel, Sendi, Parham, & Back, David J. (2021). Prescribing in COVID-19 patients: Should we take into account inflammation? British Journal of Clinical Pharmacology, 87(3), 719–721. https://doi.org/10.1111/bcp.14524

Roth, Jan A., Radevski, Gorjan, Marzolini, Catia, Rauch, Andri, Günthard, Huldrych F., Kouyos, Roger D., Fux, Christoph A., Scherrer, Alexandra U., Calmy, Alexandra, Cavassini, Matthias, Kahlert, Christian R., Bernasconi, Enos, Bogojeska, Jasmina, & Battegay, Manuel. (2021). Cohort-derived machine learning models for individual prediction of chronic kidney disease in people living with Human Immunodeficiency Virus: a prospective multicentre cohort study. Journal of Infectious Diseases, 224(7), 1198–1208. https://doi.org/10.1093/infdis/jiaa236

Stader, Felix, Courlet, Perrine, Kinvig, Hannah, Battegay, Manuel, Decosterd, Laurent A., Penny, Melissa A., Siccardi, Marco, & Marzolini, Catia. (2021). Effect of ageing on antiretroviral drug pharmacokinetics using clinical data combined with modelling and simulation. British Journal of Clinical Pharmacology, 87(2), 458–470. https://doi.org/10.1111/bcp.14402

Stader, Felix, Courlet, Perrine, Kinvig, Hannah, Penny, Melissa A., Decosterd, Laurent A., Battegay, Manuel, Siccardi, Marco, & Marzolini, Catia. (2021). Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug-Drug Interaction Magnitudes in the Elderly. Clinical Pharmacology & Therapeutics, 109(2), 471–484. https://doi.org/10.1002/cpt.2017

Surial, Bernard, Ledergerber, Bruno, Calmy, Alexandra, Cavassini, Matthias, Günthard, Huldrych F., Kovari, Helen, Stöckle, Marcel, Bernasconi, Enos, Schmid, Patrick, Fux, Christoph A., Furrer, Hansjakob, Rauch, Andri, Wandeler, Gilles, Anagnostopoulos A., Battegay M., Boni J., Braun D.L., Bucher H.C., Ciuffi A., et al. (2020). Changes in renal function after switching from TDF to TAF in HIV-infected individuals: A prospective cohort study. Journal of Infectious Diseases, 222(4), 637–645. https://doi.org/10.1093/infdis/jiaa125

Marzolini, C., Stader, F., Stoeckle, M., Franzeck, F., Egli, A., Bassetti, S., Hollinger, A., Osthoff, M., Weisser, M., Gebhard, C. E., Baettig, V., Geenen, J., Khanna, N., Tschudin-Sutter, S., Mueller, D., Hirsch, H. H., Battegay, M., & Sendi, P. (2020, July 7). Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2020.07.05.20146878

Back, David, & Marzolini, Catia. (2020). The challenge of HIV treatment in an era of polypharmacy. Journal of the International AIDS Society, 23(2), e25449. https://doi.org/10.1002/jia2.25449

Bukkems, Vera E., Colbers, Angela, Marzolini, Catia, Molto, Jose, & Burger, David M. (2020). Drug-Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals? Clinical Pharmacokinetics, 59(10), 1217–1236. https://doi.org/10.1007/s40262-020-00914-x

Burger, David M., Calmy, Alexandra, & Marzolini, Catia. (2020). Cobicistat: A case of mislabelled drug-drug interaction risk? British Journal of Clinical Pharmacology, 86(5), 834–836. https://doi.org/10.1111/bcp.14262

Courlet, Perrine, Alves Saldanha, Susana, Cavassini, Matthias, Marzolini, Catia, Choong, Eva, Csajka, Chantal, Günthard, Huldrych F., André, Pascal, Buclin, Thierry, Desfontaine, Vincent, & Decosterd, Laurent Arthur. (2020). Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV. Journal of Mass Spectrometry, 55(6), e4506. https://doi.org/10.1002/jms.4506